At 9 a.m. on August 8, the second large-scale public welfare activity of "8.8 Huixin Day" of the First Hospital of Harbin Medical University was held in the outpatient hall of the First Hospital of Harbin Medical University. More than 20 beneficiaries of heart transplantation and artificial heart implantation, cardiovascular disease treatment experts from the First Hospital of Harbin Medical University, media reporters and citizens who participated in the free clinic came to the free clinic site to witness and celebrate this festival belonging to "caring" people.
The establishment of the "Huixin Day" of the First Hospital of Harbin Medical University originated from the completion of the first pioneering operation of "artificial heart implantation in patients with terminal heart failure" in Heilongjiang Province in the Department of Cardiac Surgery of the First Hospital of Harbin Medical University in 2022, which became a milestone in the history of heart failure treatment in Longjiang and truly brought hope to patients with end-stage heart failure. The purpose of the establishment of Huixin Day is to "benefit the people in action and benefit the people in the heart", aiming to publicize and popularize the knowledge of cardiovascular disease prevention and health care, and improve the public's awareness of the prevention and treatment of cardiovascular diseases.
Chief physician Xie Baodong, a well-known expert
Chief physician of Kangkai, a well-known expert
Chief physician of Kong Yihui, a well-known expert
Chief Physician Zhang Guowei
Sun Weiju is the deputy chief physician
Chi Jing is the deputy chief physician
Wang Tengyu, Deputy Chief Physician
At the site of the free clinic, citizens lined up in front of the free clinic table with various inspection reports. The expert team of Professor Xie Baodong, director of the Department of Cardiac and Vascular Surgery, and the expert team of Professor Kong Yihui of the Department of Cardiovascular Medicine provided free health science popularization and free clinic services for the public on the spot, patiently and meticulously answered questions, put forward professional diagnosis and treatment opinions, and improved the public's understanding of heart health.
More than 20 beneficiaries of heart transplantation and artificial heart implantation showed up to tell the public about the unprecedented changes brought about by scientific and technological innovation and medical technology transformation to people's lives and health, with their own personal experience and joy of restarting their lives, which aroused enthusiastic responses from patients with heart diseases and their families who participated in the free clinic.
After the free clinic, more than 20 beneficiaries of heart transplantation and artificial heart implantation also came to Harbin Children's Park for outdoor fitness activities such as hiking.
"Cardiovascular disease is the most common disease, causing tens of millions of deaths worldwide every year, and is the number one killer of human beings, with hundreds of millions of patients suffering from cardiovascular disease in the mainland." Professor Kong Yihui said that Heilongjiang Province is a cold region, and the incidence of cardiovascular diseases caused by climate and living habits, such as aortic dissection, acute myocardial infarction, hypertension, etc., ranks among the top in the country, showing regional specificity, and the incidence of heart failure remains high.
Recently, with the selfless dedication of an organ donor, the First Hospital of Harbin Medical University successfully helped 7 patients to re-light the light of life that was about to be extinguished, including two kidney transplants, two liver transplants (split liver transplantation), two lung transplants, and one heart transplant. The heart transplant patient was off the ventilator on the same day, and after 5 days, he was able to leave the bed and pedal for exercise, and will be discharged from the hospital in the near future, he is undoubtedly lucky. Because of the scarcity and matching of donors, it is still a life barrier that is difficult for patients with end-stage heart failure to overcome in the short term.
"The number of artificial heart implants abroad has exceeded the number of heart transplants, and they can be worn for a long time." Professor Xie Baodong introduced that the artificial heart technology pioneered by the First Hospital of Harbin Medical University has become an excellent solution for patients with end-stage heart failure in Heilongjiang. Professor Xie Baodong said that heart failure has become the only cardiovascular disease that has increased in recent years, and there are hundreds of thousands of heart failure patients in Heilongjiang, and tens of thousands of people die of heart failure every year. In the First Hospital of Harbin Medical University, the system and serial treatment of heart failure have become routine, and the drug treatment, pacemaker synchronization therapy, myocardial contractility regulator therapy, stem cell gene therapy, and surgical treatment of cardiac surgery, including coronary artery bypass, incision and interventional valve replacement, heart malformation correction, heart transplantation, artificial heart implantation and other technologies can save the lives of the vast majority of heart failure patients.
At present, the First Hospital of Harbin Medical University has implanted artificial hearts for nearly 20 patients with end-stage heart failure who are about to reach the end of their lives and cannot wait for heart transplantation, and have achieved good results.
"This plenary meeting of the provincial party committee proposed that we should focus on improving the quality of people's lives and accelerate the construction of a happy Longjiang." The purpose of Huixin Day is to protect the physical and mental health of the people of Longjiang. Professor Xie Baodong said that this year coincides with the 75th anniversary of the establishment of the First Hospital of Harbin Medical University, and all the colleagues of the Department of Cardiac and Vascular Surgery of the First Hospital of Harbin Medical University and the Department of Cardiovascular Medicine responded to the call and adhered to the service tenet of the First Hospital of Harbin Medical University, taking root in Longjiang, building Longjiang, and serving the people of Longjiang.
Chi Chao
Department Profile:
The Department of Cardiac and Vascular Surgery of the First Hospital of Harbin Medical University is the largest cardiovascular surgery center in Heilongjiang Province, with nearly 2,000 cardiac surgeries per year, ranking second in Northeast China in terms of the number of surgeries, and covering all heart diseases. In terms of heart failure treatment, the department is one of the qualified units approved by the National Health Commission to carry out heart transplantation, and has successfully carried out more than 30 cases of heart transplantation in recent years, and has achieved good results. At present, nearly 20 cases of artificial heart implantation have been successfully completed, ranking first in Northeast China, marking that the First Hospital of Harbin Medical University can carry out the treatment of all end-stage heart diseases, and the diagnosis and treatment capacity of cardiac and vascular surgery has reached the advanced level in China. The Department of Cardiac and Vascular Surgery of the First Hospital of Harbin Medical University, which is constantly innovating and pioneering, practices the Healthy China strategy with practical actions to escort the heart health of the people of Longjiang.
The Department of Cardiovascular Medicine of the First Hospital of Harbin Medical University was founded in 1952 by Professor Fu Shiying, a famous cardiologist in mainland China. Professors Fu Shiying, Huang Yonglin, Meng Fanchao and Li Weimin have served as the chairman of the Cardiovascular Medicine Professional Committee of Heilongjiang Medical Association, and have created and developed the cause of cardiovascular medicine in Heilongjiang Province. Over the past 70 years, the discipline has created a number of domestic and provincial firsts, and has achieved all-round development in medicine, teaching, research and prevention, and has become a cardiology specialty with high influence and popularity in China.
The Department of Cardiology of the First Hospital of Harbin Medical University has a glorious history. It was the first to report the normal value of Chinese electrocardiogram in China, and the first to carry out research on right heart catheterization and left ventricular angiography, radiofrequency ablation and medical-engineering cooperation sonodynamics. In the treatment of coronary heart disease and arrhythmia, he has invented many international original technologies and made great contributions to the development of the field of cardiovascular intervention. In 1981, it became one of the first five doctoral degree authorization sites in China, in 2011, it was selected as one of the first batch of national key clinical specialty construction projects of the Ministry of Health, and in 2018, it was awarded the national construction project for improving the diagnosis and treatment capacity of difficult diseases. In 2020, the Northern Innovation Cardiology Academy was established to help cultivate outstanding cardiovascular talents.
At present, the Department of Cardiology has 11 wards, 512 beds, and 399 medical staff in the two campuses, making it one of the largest cardiovascular departments in China. At present, more than 30,000 inpatients with cardiovascular diseases are admitted, more than 100,000 emergency outpatient visits are admitted, and more than 10,000 interventional surgeries are performed annually. It has 17 doctoral supervisors, 54 master's supervisors, 1 Changjiang Scholar Distinguished Professor of the Ministry of Education, 3 experts with outstanding contributions from the Ministry of Health, 6 provincial experts with outstanding contributions, 6 provincial outstanding young people and 4 Longjiang scholars. In the past 5 years, he has won dozens of scientific research achievements, including 2 first prizes and 4 second prizes of the Provincial Science and Technology Progress Award, 12 national patents, 8 monographs and 272 academic papers. Among them, more than 70 journal papers have been published in Q1\Q2. He has presided over or participated in the formulation of 24 international and domestic diagnosis and treatment norms/guidelines/consensuses, and presided over more than 30 national scientific research projects, including major projects of the National Natural Science Foundation of China.
In 2015, the Department of Cardiology was rated as the only unit in Heilongjiang Province to rank among the top 10 in the evaluation of the best clinical disciplines in China. In 2016, the Department of Cardiology was nominated for the top 10 in the "Comprehensive Ranking of Chinese Hospitals"; In 2017, it was ranked 20th in the country in the "China Hospital Specialty Reputation Ranking"; In the newly released "2021 China Hospital Science and Technology Value (STEM)", it ranked 12th in the country.
After 70 years of development, the Department of Cardiology of the First Hospital of Harbin Medical University is a "big family" with culture and heritage. In line with the goal of "specialties with characteristics and experts with specialties", we have achieved full coverage of six subspecialties, including coronary heart disease, arrhythmia, hypertension, heart failure, structural heart disease and cardiac rehabilitation.